De March XVI, MMXX, duces Minjian Qinginghanhu venit ad Nanchang Maikere Medical Equipment Co., Ltd ad visitationem et intelligere situ ex conatibus reversus ad opus et productionem post Xinguan epidemiam. Sub ductu Chen Flexai, Generalis Manager de Nanchang Maikel Medical Equipment Co., Ltd., De Minjian Qinginghanhu inspecta in comitatu scriptor officium et introducta et demonstratum quidam de comitatu scriptor novum products.
Nova Product Designed by Group ------- JD1700
Product Description
Product Model:JD1700 JD1700L
Scope of Application:Haec series products providere doctores cum loci luminatione durante examen et surgery. Est idoneam ad auxilia lux fons in hospitium outpatient department et operating locus.
Product compositionem:ex lucerna possessor, bracket, potentia copia etc.
Munus
Hoc productum adoptat wide voltage potentia copia et XII summus potentia lux fontibus. Lucerna cap adoptat optical lens Conventus collectam lucem. Lux macula est uniformis et clara.
Hoc productum est implemented per consilio et productionem GB 9706.1-2007 "Medical electrica apparatu-Part I: General Requirements ad salutem" et "Product Technical Requirements ad Chirurgicam Auxiliares lucendi."
Specificatio
I, Power Specifications
Input intentione: 100-200V ~ L / 60Hz
Output Voltage: 12V / 2a ~ 2.5A
II, color temperatus: (IV) ~ 5000k
III, illuminance: (V) CC ~ 67000lux
V, rete pondus:
Monte: V ~ 7kg
Lampam Armate: 2.8 ~ 4.0kg
Lucerna Holder: 1.4 ~ 2.4kg
Base: XII ~ 14kg
Riser: 2.8 ~ ~ 3.8kg
VI, Safety Type: I type, BF Type application parte
Productum interface
Figura I altiore specie JD1700
Figura II altiore species JD1700L
I, rotating iuncturam II, Iungo Armate III, lucerna Cover IV, lucerna habitationi
V, Imperium Button VI, Sensoria SWITCH
Figura III schematic diagram de lucerna possessor
I. Postquam autem potestas est in, in switch button (V) seu sensorem switch (VI) potest ad lucem usque ad fabrica et satus opus.
II. Et claritas luminis potest esse adaequatum per switch button (V), aut ponere manum tuam sub sensorem switch (VI).
Post tempus: Mar-18-2021